Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Power3 Medical has introduced BC-SeraPro, a breast cancer test to twelve Middle Eastern countries: Bahrain, Egypt, Iraq, Jordan, Kuwait, Lebanon, Saudi Arabia, Oman, Qatar, Syria, United Arab Emirates, and Yemen.
Subscribe to our email newsletter
BC-SeraPro, a simple, minimally invasive blood test for breast cancer, analyzes biomarkers, or specific proteins, in a woman’s blood serum, to detect breast cancer. In addition to providing the Middle East with a diagnostic test more suitable for their culture, the test will supplement the traditional mammography and MRI.
Essam Sheta, researcher at Power3 Medical, said: “We believe the test provides a promising alternative for the detection of breast cancer at its earlier stages, thereby alleviating the problems that so many Middle Eastern women face because of late-stage detection.”